Programs & Research

For many in the PF community, the pace of change is too slow. Awareness of the disease is almost invisible. Misdiagnosis is common. Access to care and medications are lacking. And the patient experience is frustrating. But together, we can influence change. Today, we are seeking new ways to improve the diagnostic experience, accelerate breakthroughs in medicine, and enhance quality of life.

RESEARCH

Our Commitment

to Change

Our Commitment

to Change

Three Lakes Consortium for PF (TLC4PF)

The Three Lakes Consortium for PF (TLC4PF) aims to accelerate therapies for the treatment of PF.

B4PF: Understanding Early Disease

To develop therapies that prevent the development of PF, it is essential to study the earliest aspects of disease pathogenesis.

A Global Collaboration for PF

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is a clinically focused research program funded by the Australian National Health and Medical Research Council.

Improving Time to Diagnosis

Timing is everything. An earlier diagnosis means patients are informed and can take steps to preserve their health and start therapies sooner, potentially slowing disease progression. Thanks to our partners in the PF community, we are closer to understanding the diagnostic journey and knowing one's risk of PF.

DIAGNOSIS

Learn More

Improving Time

to Diagnosis

Improving Timely Diagnosis

Timely and accurate diagnosis for Interstitial Lung Diseases (ILDs) remains a challenge despite scientific advancements and increased information sharing online.

Time to Diagnosis and Earlier Detection

PF is a progressive and fatal lung disease. Most patients are referred to pulmonary physicians and other experts late in the course of their disease.

Influence of Inhaled Exposures in PF

Interstitial Lung Diseases (ILDs) are associated with inhaled environmental and occupational exposures, including air pollution, second-hand smoke, vapors, gases, dusts, and fumes.

Accelerating Therapies

Accelerating next generation therapies begins from an innovative idea that is supported, nurtured, and tested. Only then, can breakthroughs in medicine occur. We are on the cusp of new discoveries that will someday stop PF in its tracks.

RESEARCH

Learn More

Enhancing Quality of Life

Excellence in care and connection to information improves the quality of life for patients and provides comfort for families during difficult times. Together with our partners, we seek out ways to support patients and improve the care they receive so they can focus on their health and well-being.

CARE

Learn More

PF Warriors

PF Warriors serves a global community of PF/ILD patients and their families, supporters, and caregivers.

Supporting Patient Care

Baylor Scott & White Dallas Foundation is executing a best practices program to help support patients and families after a diagnosis of PF.

Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation (PFF) mobilizes people and resources to increase access to high quality care and leads research for a cure so people with PF can live longer, healthier lives.

Improving Timely Diagnosis

Timely and accurate diagnosis for Interstitial Lung Diseases (ILDs) remains a challenge despite scientific advancements and increased information sharing online.

Time to Diagnosis and Earlier Detection

PF is a progressive and fatal lung disease. Most patients are referred to pulmonary physicians and other experts late in the course of their disease.

Influence of Inhaled Exposures in PF

Interstitial Lung Diseases (ILDs) are associated with inhaled environmental and occupational exposures, including air pollution, second-hand smoke, vapors, gases, dusts, and fumes.

Featured Programs

Three Lakes Consortium for PF (TLC4PF)

The Three Lakes Consortium for PF (TLC4PF) aims to accelerate therapies for the treatment of PF.

B4PF: Understanding Early Disease

To develop therapies that prevent the development of PF, it is essential to study the earliest aspects of disease pathogenesis.

A Global Collaboration for PF

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is a clinically focused research program funded by the Australian National Health and Medical Research Council.

PF Warriors

PF Warriors serves a global community of PF/ILD patients and their families, supporters, and caregivers.

Supporting Patient Care

Baylor Scott & White Dallas Foundation is executing a best practices program to help support patients and families after a diagnosis of PF.

Pulmonary Fibrosis Foundation

The Pulmonary Fibrosis Foundation (PFF) mobilizes people and resources to increase access to high quality care and leads research for a cure so people with PF can live longer, healthier lives.